Oramed Pharmaceuticals Inc. (NASDAQ: ORMP)
$2.56
+0.0300 ( +1.19% ) 101.9K
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Market Data
Open
$2.56
Previous close
$2.53
Volume
101.9K
Market cap
$104.01M
Day range
$2.50 - $2.60
52 week range
$1.67 - $3.67
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jun 26, 2024 |
8-k | 8K-related | 13 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
3 | Insider transactions | 1 | Jun 21, 2024 |
ars | Annual reports | 1 | Jun 20, 2024 |
def | Proxies and info statements | 5 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 10, 2024 |
8-k | 8K-related | 13 | Jun 10, 2024 |
8-k | 8K-related | 13 | May 13, 2024 |
10-q | Quarterly Reports | 51 | May 09, 2024 |